The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES‐34)
Open accessAbstract
Aim: To compare the prevalence of metabolic syndrome (MS) using the World Health Organisation (WHO), Adult Treatment Panel III (ATPIII) and International Diabetes Federation (IDF) criteria of MS in an urban south Indian population, and their ability to identify coronary artery disease (CAD) in males and females. Methods: Chennai Urban Rural Epidemiology Study (CURES) is one of the largest epidemiological studies on diabetes carried out in India, in which 26 001 individuals aged ≥20 years were screened using systematic random sampling method. Every tenth subject recruited in Phase 1 of CURES was requested to participate in Phase 3, and the response rate was 90.4%. An oral glucose tolerance test (OGTT) was performed in all individuals except self‐reported diabetic subjects. Anthropometric measurements and lipid estimations were done in all subjects and the prevalence of MS estimated using the three criteria. Diagnosis of CAD, made by resting 12 lead ECG, was compared by the three criteria of MS. Results: MS was identified in 546 subjects (23.2%) by WHO criteria, 430 subjects (18.3%) by ATPIII criteria and 607 subjects (25.8%) by IDF criteria. Only 224 of these subjects were identified by all the three criteria. There was an increased risk of probable CAD in MS subjects diagnosed by WHO criteria (odds ratio (OR) 3.86, 95% Confidence Interval (CI), 2.37–6.29, p < 0.001), compared to ATPIII criteria (OR 2.19, 95% CI 1.30–3.67, p < 0.05) and IDF criteria (OR 1.90, 95% CI 1.16–3.12, p < 0.05). The WHO criteria marked out a much higher population for CAD risk compared to ATPIII and IDF criteria in males, but not in females. Conclusion: In Asian Indians, the WHO, ATPIII and IDF criteria of MS identify different individuals. The WHO criteria identify a greater number of CAD subjects in males, but not in females. Copyright © 2006 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2745 · Cited by 1,194
Anand, S. S., Yusuf, S., Vuksan, V., Devanesen, S., Teo, K. K., Montague, P. A., Kelemen, L., Yi, C., Lonn, E., Gerstein, H., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02502-2 · Cited by 1,066
Prevalence of the metabolic syndrome and overweight among adults in China
Gu, D., Reynolds, K., Wu, X., Chen, J., Duan, X., Reynolds, R. F., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66375-1 · Cited by 917
Tan, C.-E., Ma, S., Wai, D., Chew, S.-K., & Tai, E.-S. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1182 · Cited by 824
Stern, M. P., Williams, K., González-Villalpando, C., Hunt, K. J., & Haffner, S. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2676 · Cited by 735
Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
Dekker, J. M., Girman, C., Rhodes, T., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · Circulation · doi:10.1161/circulationaha.104.516948 · Cited by 632
A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions
Ford, E. S., & Giles, W. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.575 · Cited by 616
Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study
Azizi, F., Salehi, P., Etemadi, A., & Zahedi-Asl, S. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00066-4 · Cited by 526
Resnick, H. E., Jones, K., Ruotolo, G., Jain, A. K., Henderson, J., Lu, W., & Howard, B. V. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.861 · Cited by 427
Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria
Ramachandran, A., Snehalatha, C., Satyavani, K., Sivasankari, S., & Vijay, V. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00060-3 · Cited by 395
Syndrome X and Mortality: A Population-based Study
Trevisan, M., Liu, J., Bahsas, F. B., Menotti, A., & for the Risk Factor and Life Expectancy Research Group (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009572 · Cited by 388
Prevalence of metabolic syndrome in an Indian urban population
Gupta, R., Deedwania, P. C., Gupta, A., Rastogi, S., Panwar, R. B., & Kothari, K. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.11.003 · Cited by 314
Deepa, M., Pradeepa, R., Rema, M., Mohan, A. R., Deepa, R., Shanthirani, S., & Mohan, V. (2003) · PubMed · Cited by 311
Self-citationThe Metabolic Syndrome in Older Individuals: Prevalence and Prediction of Cardiovascular Events
Scuteri, A., Najjar, S. S., Morrell, C. H., & Lakatta, E. G. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.882 · Cited by 280
Prevalence of the Metabolic Syndrome Among Omani Adults
Al-Lawati, J. A., Mohammed, A. J., Al-Hinai, H. Q., & Jousilahti, P. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1781 · Cited by 267
Mohan, V., Shanthirani, S., Deepa, R., Premalatha, G., Sastry, N. G., & Saroja, R. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00421.x · Cited by 251
Self-citationPrevalence and Factor Analysis of Metabolic Syndrome in an Urban Korean Population
Oh, J.-Y., Hong, Y. S., Sung, Y.-A., & Barrett-Connor, E. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2027 · Cited by 205
Prevalence of the Metabolic Syndrome and Its Components
Ilanne-Parikka, P., Eriksson, J. G., Lindström, J., Hämäläinen, H., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2135 · Cited by 196
Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2000) · Diabetologia · doi:10.1007/s001250050023 · Cited by 193
Thomas, G. N., Ho, S.-Y., Janus, E. D., Lam, K. S. L., Hedley, A. J., & Lam, T. H. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.07.022 · Cited by 178
The Prevalence of the Metabolic Syndrome Among Arab Americans
Jaber, L. A., Brown, M. B., Hammad, A., Zhu, Q., & Herman, W. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.234 · Cited by 162
The Metabolic Syndrome in the West Bank Population
Rahim, H. F. A., Husseini, A. S., Bjertness, E., Giacaman, R., Gordon, N. H., & Jervell, J. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.275 · Cited by 147
Population Comparison of Two Clinical Approaches to the Metabolic Syndrome
Adams, R., Appleton, S., Wilson, D. H., Taylor, A. W., Grande, E. D., Chittleborough, C., Gill, T. K., & Ruffin, R. E. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2777 · Cited by 140
Shiwaku, K., Nogi, A., Kitajima, K., Anuurad, E., Enkhmaa, B., Yamasaki, M., Kim, J., Kim, I., Lee, S., Oyunsuren, T., et al. (2005) · Journal of Occupational Health · doi:10.1539/joh.47.126 · Cited by 117
High prevalence of metabolic syndrome in Hong Kong Chinese—comparison of three diagnostic criteria
Ko, G. T.-C., Cockram, C. S., Chow, C., Yeung, M. W., Chan, W. B., So, W., Chan, N. N., & Chan, J. C. N. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.11.015 · Cited by 108
Bo, S., Gentile, L., Ciccone, G., Baldi, C., Benini, L., Dusio, F., de Lucia, C., Forastiere, G., Nuti, C., Cassader, M., et al. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.561 · Cited by 78
Ma, S. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg199 · Cited by 68
Guerrero‐Romero, F., & guez-Morán, M. R. I. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2588a · Cited by 64
The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City
Son, L. N. T. D., Kunii, D., Hung, N. T. K., Sakai, T., & Yamamoto, S. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.07.014 · Cited by 61
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Metabolic syndrome: definitions and controversies
Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-48 · Cited by 1,565
“This increase with age continues up to the sixth decade; however, different studies have estimated a variable prevalence after the sixth or seventh decades, probably as individuals most susceptible to obesity-related mortality have already died [22,24,26].”
BackgroundResultGrundy, S. M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.151092 · Cited by 1,563
Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies
O'Neill, S., & O'Driscoll, L. (2015) · Obesity Reviews · doi:10.1111/obr.12229 · Cited by 1,547
Metadata
- Authors
- Deepa, M., Farooq, S., Datta, M., Deepa, R., & Mohan, V.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2006-06-05
- Volume
- 23
- Issue
- 2
- Pages
- 127-134
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W2082302888
- Cited by
- 307
- References
- 36
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.